Nektar Therapeutics
Clinical-stage biopharmaceutical company developing a pipeline of drug candidates. Learn more
Launch date
Employees
Market cap
€209m
Enterprise valuation
€65m (Public information from Sep 2024)
Share price
$1.26 NKTR
San Carlos California (HQ)
Authorizing premium user...